Clinical Trial Applications - Approved: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | Date Approved | |
|---|---|---|---|---|---|
251. |
ECCT/22/03/10 | Solidarity Trial Vaccines Solidarity Trial Vaccines: An international randomised trial of candidate vaccines against COVID-19 |
Principal Investigator(s) 1. Ayallo, John Mark O, AYALLO 2. Prof KAWANGO AGOT AGOT 3. DR. LUCAS TINA OTIENO OTIENO 4. DR.MARICIANA ONONO ONONO 5. DR.JANET OYIEKO OYIEKO 6. DR.Fredrick Kipyego Sawe SAWE 7. DR. MICHAEL M MUTUA Mutua 8. Dr Joshua Kimani KIMANI 9. DR. IRENE A. MUGENYA MUGENYA Site(s) in Kenya 1. SWOP (Nairobi City county) 2. K-IRDO –KISUMU (Kisumu county) 3. VIBRI- VICTORIA BIOMEDICAL RESEARCH INSTITUTE –KISUMU (Kisumu county) 4. KEMRI-CENTRE FOR MICROBIOLOGY RESEARCH (CMR) LUMUMBA –KISUMU (Kisumu county) 5. KEMRI –CENTRE FOR CLINICAL RESEARCH BUTERE(CCR) (Kakamega county) 6. Kenya Medical Research Institute/Walter Reed Project (KEMRI/WRP) (Kericho county) 7. UNIVERSITY OF NAIROBI- KAVI- KANGEMI (Nairobi City county) 8. UNIVERSITY OF NAIROBI- KAVI- KNH (Nairobi City county) |
23-05-2022 |
View |
252. |
ECCT/22/01/04 | SKYSCRAPER 07 A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ATEZOLIZUMAB WITH OR WITHOUT TIRAGOLUMAB (ANTI-TIGIT ANTIBODY) IN PATIENTS WITH UNRESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA WHOSE CANCERS HAVE NOT PROGRESSED FOLLOWING DEFINITIVE CONCURRENT CHEMORADIOTHERAPY |
Principal Investigator(s) 1. Fredrick Chite Asirwa 2. Mansoor Saleh Site(s) in Kenya 1. Aga Khan University, Nairobi (Nairobi City county) 2. International Cancer Institute (Uasin Gishu county) |
22-05-2022 |
View |
253. |
ECCT/21/11/06 | RESOLVE A Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy of Voxelotor for the Treatment of Leg Ulcers in Patients with Sickle Cell Disease |
Principal Investigator(s) 1. Videlis Nduba Site(s) in Kenya 1. KEMRI/CRDR Siaya Clinical Research Annex (Siaya county) 2. KEMRI CRDR Clinical Research Clinic Nairobi (Nairobi City county) |
20-05-2022 |
View |
254. |
ECCT/22/02/01 | An Open label Inclacumab study An Open-Label Extension Study to Evaluate the Long-Term Safety of Inclacumab Administered to Participants with Sickle Cell Disease Who Have Participated in an Inclacumab Clinical Trial |
Principal Investigator(s) 1. Bernhards Ragama Ogutu 2. Fredrick Asirwa Chite 3. Videlis N nduba 4. Prof Jessie N Githanga Site(s) in Kenya 1. Strathmore University Medical Centre (Nairobi City county) 2. International Cancer Institute (ICI)-Eldorate (Uasin Gishu county) 3. KEMRI/CRDR (Nairobi City county) 4. KEMRI Siaya Clinical Research Annex (Siaya county) 5. Gertrude’s Children’s Hospital. (Nairobi City county) 6. Strathmore University Medical Centre (Nairobi City county) |
16-05-2022 |
View |
255. |
ECCT/22/01/05 | STEP-Mag Trial Simplified Treatment for Eclampsia Prevention using Magnesium sulfate: A phase III, randomized, open label, active controlled, multicountry, multicentre, non-inferiority trial of simplified magnesium sulfate regimen for eclampsia prophylaxis (The STEP-Mag Trial) |
Principal Investigator(s) 1. Zahida Qureshi Site(s) in Kenya 1. Wamalwa Kijana TRH (Trans Nzoia county) 2. Mama Lucy Kibaki Hospital (Nairobi City county) 3. Mbagathi County referral Hospital (Nairobi City county) |
15-05-2022 |
View |
256. |
ECCT/22/03/03 | HVTN 140/HPTN 101 A phase 1 dose-escalation clinical trial to evaluate the safety, tolerability, and pharmacokinetics of PGDM1400LS alone and in combination with VRC07-523LS and PGT121.414.LS in healthy, HIV-uninfected adult participants_HVTN 140/HPTN 101 |
Principal Investigator(s) 1. Josphat kosgei Site(s) in Kenya KEMRI WRP, KERICHO |
12-05-2022 |
View |
257. |
ECCT/22/01/03 | lidERA A Phase III, Randomized, Open-Label, Multicenter Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared with Physician’s Choice of Adjuvant Endocrine Monotherapy in Patients with Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer |
Principal Investigator(s) 1. Mansoor Saleh Site(s) in Kenya 1. International Cancer Institute (ICI) (Uasin Gishu county) 2. Aga Khan University Hospital (Nairobi City county) |
08-05-2022 |
View |
258. |
ECCT/22/03/04 | VIBRI COVID-19-001/2021 A Multi-Centre, Randomized, Double Blind, Phase 2b Trial to Evaluate the Safety and Immunogenicity of Janssen Ad26COVS1 and Novavax NVX-CoV2373 COVID-19 vaccines for Homologous and Heterologous Boosting in Adolescents and Adults Aged 12 to 64 Years with and without HIV infection in 3 African Countries (Kenya, Democratic Republic of Congo, and Rwanda). |
Principal Investigator(s) 1. Dr. Lucas Otieno Tina Site(s) in Kenya Victoria Biomedical Research Institute, |
04-05-2022 |
View |
259. |
ECCT/21/10/03 | Validation of Chloe SED Validation of Chloe SED, a reusable, low-cost syringe extension device for the provision of paracervical analgesia during gynecologic procedures |
Principal Investigator(s) 1. Stephen Gwer Site(s) in Kenya 1. Jaramogi Oginga Odinga Teaching and Referral Hospital (JOOTRH) (Kisumu county) 2. Kisii Teaching & Referral Hospital (KTRH) (Kisii county) |
29-04-2022 |
View |
260. |
ECCT/22/01/02 | CoVPN 3008 Multi-Center, Randomized, Efficacy Study of COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern |
Principal Investigator(s) 1. Ben Madeke Andagalu Site(s) in Kenya 1. KEMRI -USAMRD-A, Kombewa Clinical Research Centre (Kisumu county) 2. KEMRI-CGHR (Kisumu county) |
14-04-2022 |
View |